Source: BioPortfolio

KineMed: KineMed Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 26042017 Prices from USD $250

SummaryKineMed Inc KineMed focuses on offering the drug development services. The company utilizes isotope labeling mass spectrometry and other techniques to observe the activity of biochemical pathways measure molecular fluxes within the pathways and moni...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
David Fineman's photo - Chairman & CEO of KineMed

Chairman & CEO

David Fineman

CEO Approval Rating

69/100

Read more